We are live on ! Find out more
KALA icon

KALA BIO

15 hedge funds and large institutions have $4.88M invested in KALA BIO in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,033% more capital inflows, than outflows

Capital inflows: $758K | Capital outflows: $66.9K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

15% more funds holding

Funds holding: 13 → 15 (+2)

3.38% more ownership

Funds ownership: 19.55% → 22.93% (+3.4%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KALA Hedge Fund Activity: Q1 2024 in Review

15 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2024, worth a combined $4.88M — up 33% from $3.68M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new KALA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $535K. The largest seller was Bank of America, exiting entirely with an estimated $22.3K sold.

  • 15 institutional investors held KALA BIO (KALA) as of Q1 2024, up from 13 in Q4 2023.
  • Funds reported $4.88M of KALA BIO stock for Q1 2024, up 33% quarter-over-quarter.
  • 3 funds opened new KALA BIO positions in Q1 2024 and 1 closed out, a net change of +2 holders.
  • The largest KALA BIO buyer in Q1 2024 was UBS O'Connor, an estimated $535K added.
  • The largest KALA BIO seller in Q1 2024 was Bank of America, an estimated $22.3K sold.

Based on aggregated 13F filings for Q1 2024.